Rallis Chris A
Fennec Pharmaceuticals Inc. · Director
Rallis Chris A is listed in filings as Director at Fennec Pharmaceuticals Inc.. This profile follows SEC Form 4 activity through May 12, 2026, including sale activity. Recent filings connect the profile to Fennec Pharmaceuticals Inc. (FENC). The current snapshot covers public activity from Jul 8, 2024 to May 12, 2026. Reported amounts are shown as $58.8K to $5.0K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
Latest Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $59k8.3k shares | SellMay 11, 2026 | $7.04 | $10.50 |